Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexuprazan Timing of Administration in Erosive Esophagitis
NCT04888819Unknown
- Sponsor
- Konkuk University Medical Center
- Start
- Feb 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fexuprazan in erosive esophagitis (EE) (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Healing rate at week 4. Status: unknown.
02
Drugs
fexuprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT04888819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04888819.